• Something wrong with this record ?

Vascular access as a survival factor for the hemodialysis population: a retrospective study

M. Zavacka, A. Zelko, A. Madarasova Geckova, M. Majernikova, J. Pobehova, P. Zavacky

. 2020 ; 39 (6) : 525-531. [pub] 20200609

Language English Country Italy

Document type Journal Article

BACKGROUND: The creation of vascular access is an essential condition for providing hemodialysis, which remains the only option for most patients suffering from end-stage renal disease. Selection of the type of vascular access affects patients' clinical outcomes, access maintenance frequency, risk of infection and major adverse cardiac events during dialysis. To improve the decision-making process, we performed a retrospective clinical data analysis of dialyzed patients and critically compared the survival rates between two types of vascular access applied during dialysis therapy during a 5 years follow-up period. METHODS: Using nationally representative data from 18 dialysis centers across Slovakia, we explore and compare survival rates of 960 adult patients undergoing hemodialysis using either a central venous catheter (CVC) or an arteriovenous fistula (AVF). Length of dialysis, protein malnutrition and comorbidities were examined as possible covariates that might influence survival rates. RESULTS: Chances of surviving for a one-year period were higher by 52% in AVF patients compared to CVC patients (HR 1.52; 95% CI 1.27-1.83; P<0.001) regardless of age, sex, nutritional status, time spent on dialysis and comorbidities. The presence of cardiac congestion (HR 1.26 [95% CI 1.06-1.50], P<0.01) and malnutrition (protein malnutrition: HR 0.98 [95% CI 0.96-1.00], P<0.05; lean tissue index: HR 0.79 [95% CI 0.67-0.93], P<0.01) decreases chances for survival. CONCLUSIONS: A functional arteriovenous fistula is a significant predictor of survival in the population dependent on hemodialysis, independently of sociodemographic parameters and serious comorbidities. Therefore, if various types of vascular accesses are applicable for the patient, AVF should be prioritized over CVC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026378
003      
CZ-PrNML
005      
20211026132940.0
007      
ta
008      
211013s2020 it f 000 0|eng||
009      
AR
024    7_
$a 10.23736/S0392-9590.20.04401-6 $2 doi
035    __
$a (PubMed)32519532
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Zavacka, Martina $u Clinic of Vascular Surgery, East Slovak Institute of Cardiovascular Diseases, Kosice, Slovak Republic
245    10
$a Vascular access as a survival factor for the hemodialysis population: a retrospective study / $c M. Zavacka, A. Zelko, A. Madarasova Geckova, M. Majernikova, J. Pobehova, P. Zavacky
520    9_
$a BACKGROUND: The creation of vascular access is an essential condition for providing hemodialysis, which remains the only option for most patients suffering from end-stage renal disease. Selection of the type of vascular access affects patients' clinical outcomes, access maintenance frequency, risk of infection and major adverse cardiac events during dialysis. To improve the decision-making process, we performed a retrospective clinical data analysis of dialyzed patients and critically compared the survival rates between two types of vascular access applied during dialysis therapy during a 5 years follow-up period. METHODS: Using nationally representative data from 18 dialysis centers across Slovakia, we explore and compare survival rates of 960 adult patients undergoing hemodialysis using either a central venous catheter (CVC) or an arteriovenous fistula (AVF). Length of dialysis, protein malnutrition and comorbidities were examined as possible covariates that might influence survival rates. RESULTS: Chances of surviving for a one-year period were higher by 52% in AVF patients compared to CVC patients (HR 1.52; 95% CI 1.27-1.83; P<0.001) regardless of age, sex, nutritional status, time spent on dialysis and comorbidities. The presence of cardiac congestion (HR 1.26 [95% CI 1.06-1.50], P<0.01) and malnutrition (protein malnutrition: HR 0.98 [95% CI 0.96-1.00], P<0.05; lean tissue index: HR 0.79 [95% CI 0.67-0.93], P<0.01) decreases chances for survival. CONCLUSIONS: A functional arteriovenous fistula is a significant predictor of survival in the population dependent on hemodialysis, independently of sociodemographic parameters and serious comorbidities. Therefore, if various types of vascular accesses are applicable for the patient, AVF should be prioritized over CVC.
650    12
$a arteriovenózní zkrat $x škodlivé účinky $7 D001166
650    12
$a centrální žilní katétry $x škodlivé účinky $7 D062905
650    _2
$a lidé $7 D006801
650    12
$a chronické selhání ledvin $x diagnóza $x terapie $7 D007676
650    _2
$a dialýza ledvin $x škodlivé účinky $7 D006435
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Zelko, Aurel $u Department of Health Psychology and Research Methodology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovak Republic
700    1_
$a Madarasova Geckova, Andrea $u Department of Health Psychology and Research Methodology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovak Republic $u Olomouc University Social Health Institute, Palacky University of Olomouc, Olomouc, Czech Republic
700    1_
$a Majernikova, Maria $u First Clinic of Surgery, Louis Pasteur University Hospital, Kosice, Slovak Republic
700    1_
$a Pobehova, Jana $u Clinic of Vascular Surgery, East Slovak Institute of Cardiovascular Diseases, Kosice, Slovak Republic
700    1_
$a Zavacky, Peter $u Fresenius Medical Care - Dialysis Services Slovakia, Louis Pasteur University Hospital, Kosice, Slovak Republic - peterzavacky963@gmail.com
773    0_
$w MED00002267 $t International angiology : a journal of the International Union of Angiology $x 1827-1839 $g Roč. 39, č. 6 (2020), s. 525-531
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32519532 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132947 $b ABA008
999    __
$a ok $b bmc $g 1715178 $s 1146885
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 39 $c 6 $d 525-531 $e 20200609 $i 1827-1839 $m International angiology $n Int Angiol $x MED00002267
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...